Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

被引:23
作者
Lifson, A. R. [1 ]
Grandits, G. A. [1 ]
Gardner, E. M. [2 ]
Wolff, M. J. [3 ]
Pulik, P. [4 ]
Williams, I. [5 ]
Burman, W. J. [2 ]
机构
[1] Univ Minnesota, Minneapolis, MN 55454 USA
[2] Denver Publ Hlth, Denver, CO USA
[3] Fdn Arriaran, Santiago, Chile
[4] Hosp Infect Dis, Warsaw, Poland
[5] UCL, London, England
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
antiretroviral therapy; HIV; quality of life; FORM HEALTH SURVEY; PSYCHOLOGICAL SYMPTOMS; VIRAL LOADS; CD4; COUNTS; THERAPY; IMPACT; INFECTION; HAART; PEOPLE; SCALES;
D O I
10.1111/hiv.12237
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectivesWith HIV treatment prolonging survival and HIV infection now managed as a chronic illness, quality of life (QOL) is important to evaluate in persons living with HIV (PLWH). We assessed at study entry the QOL of antiretroviral-naive PLWH with CD4 counts >500 cells/L in the Strategic Timing of AntiRetroviral Treatment (START) clinical trial. MethodsQOL was assessed with: (1) a visual analogue scale (VAS) for self-assessment of overall current health; (2) the Short-Form 12-Item Version 2 Health Survey((R)) (SF-12V2), for which responses are summarized into eight individual QOL domains plus component summary scores for physical health [the Physical Health Component Summary (PCS)] and mental health [the Mental Health Component Summary (MCS)]. The VAS and eight domain scores were scaled from 0 to 100. Mean QOL measures were calculated overall and by demographic, clinical and behavioural factors. ResultsA total of 4631 participants completed the VAS and 4119 the SF-12. The mean VAS score (with standard deviation) was 80.915.7. Mean SF-12 domain scores were lowest for vitality (66.3 +/- 26.4) and mental health (68.6 +/- 21.4), and highest for physical functioning (89.3 +/- 23.0) and bodily pain (88.0 +/- 21.4). Using multiple linear regression, PCS scores were lower (P<0.001) for Asians, North Americans, female participants, older participants, and those with less education, longer duration of known HIV infection, alcoholism/substance dependence and body mass index 30kg/m(2). MCS scores were highest (P<0.001) for Africans, South Americans and older participants, and lowest for female participants, current smokers and those with alcoholism/substance dependence. ConclusionsIn this primarily healthy population, QOL was mostly favourable, emphasizing that it is important that HIV treatments do not negatively impact QOL. Self-assessed physical health summary scores were higher than mental health scores. Factors such as older age and geographical region had different effects on perceived physical and mental health.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 34 条
  • [1] Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949
  • [2] Olsen S J, 2000, MMWR CDC Surveill Summ, V49, P1
  • [3] Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study
    Babiker, Abdel G.
    Emery, Sean
    Faetkenheuer, Gerd
    Gordin, Fred M.
    Grund, Birgit
    Lundgren, Jens D.
    Neaton, James D.
    Pett, Sarah L.
    Phillips, Andrew
    Touloumi, Giota
    Vjecha, Michael J.
    [J]. CLINICAL TRIALS, 2013, 10 : S5 - S36
  • [4] Clinical management of depression and anxiety in HIV-infected adults
    Basu, S
    Chwastiak, LA
    Bruce, RD
    [J]. AIDS, 2005, 19 (18) : 2057 - 2067
  • [5] Impact of Antiretroviral Therapy on Quality of Life in HIV-Infected Southeast Asian Children in the PREDICT Study
    Bunupuradah, Torsak
    Kosalaraksa, Pope
    Vibol, Ung
    Hansudewechakul, Rawiwan
    Sophonphan, Jiratchaya
    Kanjanavanit, Suparat
    Ngampiyaskul, Chaiwat
    Wongsawat, Jurai
    Luesomboon, Wicharn
    Vonthanak, Saphonn
    Ananworanich, Jintanat
    Ruxrungtham, Kiat
    Puthanakit, Thanyawee
    [J]. AIDS PATIENT CARE AND STDS, 2013, 27 (11) : 596 - 603
  • [6] Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act
    Burgoyne, Robert W.
    Tan, Darrell H. S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 469 - 473
  • [7] The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life
    Burman, William J.
    Grund, Birgit
    Roedige, Mollie P.
    Friedland, Gerald
    Darhyshire, Janet
    Wu, Albert W.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (02) : 185 - 193
  • [8] QUALITY-OF-LIFE - CONCEPTS AND DEFINITION
    CELLA, DF
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1994, 9 (03) : 186 - 192
  • [9] Quality of life in HIV subtype C infection among asymptomatic subjects and its association with CD4 counts and viral loads - a study from South India
    Chandra, Prabha S.
    Gandhi, Charu
    Satishchandra, P.
    Kamat, Anupa
    Desai, Anita
    Ravi, V.
    Ownby, Raymond L.
    Subbakrishna, D. K.
    Kumar, Mahendra
    [J]. QUALITY OF LIFE RESEARCH, 2006, 15 (10) : 1597 - 1605
  • [10] Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?
    de Boer, AGEM
    van Lanschot, JJB
    Stalmeier, PFM
    van Sandick, JW
    Hulscher, JBF
    de Haes, JCJM
    Sprangers, MAG
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (02) : 311 - 320